Roche AG, of Basel, Switzerland, said its member firm, Ventana Medical Systems Inc., entered an agreement with Merck KGaA, of Darmstadt, Germany, to collaborate with Merck's biopharmaceutical division on the development and commercialization of a companion diagnostic for an undisclosed target using Ventana's diagnostic assays.